Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization-Reference-Cited by-同舟云学术

Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization

Published:2021-11 Issue: Volume:224 Page:113673
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Li Mu-Chun,Lin Wen-Hsing,Wang Pei-Chen,Su Yu-Chieh,Chen Pei-Yi,Fan Chu-Min,Chen Ching-Ping,Huang Chen-Lung,Chiu Chun-Hsien,Chang Ling,Chen Chiung-Tong,Yeh Teng-Kuang,Hsieh Hsing-Pang^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference45 articles.

1. Trk receptor tyrosine kinases: a bridge between cancer and neural development;Nakagawara;Canc. Lett.,2001

2. TRK receptors: roles in neuronal signal transduction;Huang;Annu. Rev. Biochem.,2003

3. The neurotrophin family of neurotrophic factors: an overview;Skaper;Methods Mol. Biol.,2012

4. NTRK fusion-positive cancers and TRK inhibitor therapy;Cocco;Nat. Rev. Clin. Oncol.,2018

5. Oncogenes in solid human tumours;Pulciani;Nature,1982

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanism of action and chemical synthesis of FDA newly approved drug molecules;Drug Development Research;2024-09

2. Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment;Journal of Medicinal Chemistry;2024-06-24

3. Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib;Acta Pharmaceutica Sinica B;2024-02

4. Recent advances in the discovery of tropomyosin receptor kinases TRKs inhibitors: A mini review;European Journal of Medicinal Chemistry;2023-10

5. Structure-Based Optimization of the Third Generation Type II Macrocycle TRK Inhibitors with Improved Activity against Solvent-Front, xDFG, and Gatekeeper Mutations;Journal of Medicinal Chemistry;2023-09-07